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Abstract
Summary The activity index of stearoyl-CoA desaturase
(SCD), a key enzyme in lipogenesis, was associated with
increased risk of fracture in a longitudinal population-based
cohort of men. This indicates that elevated levels of
endogenous lipogenesis increase the risk of fracture and
suggest a role for saturated fat in the pathogenesis of
osteoporosis.
Introduction Osteoblasts and marrow adipocytes are de-
rived from a common mesenchymal progenitor, and
experimental studies have indicated that increased adipo-
genesis can occur at the expense of osteoblasts, leading to
bone loss. Stearoyl-CoA desaturase (SCD) converts satu-
rated to monounsaturated fatty acids and is a key enzyme in
lipogenesis.
Methods Analysis was performed in a population-based,
longitudinal cohort study of men (n=2009). A product-to-
precursor index (palmitoleic acid/palmitic acid) was used to
estimate SCD activity in fasting serum analyzed in samples
obtained at enrollment at age 50 years. Fractures were
documented in 422 men during 35 years of follow-up. Cox
regression analysis was used to determine the risk of
fracture according to SCD activity index.
Results The risk of fracture was highest among men with
the highest levels of SCD activity index. Multivariable
analysis of the risk of fracture in the highest quintile as
compared to the lowest one showed that the rate ratio was
1.71 (95% CI 1.26–2.33) for any fracture, with an estimated
population attributable risk of 15%. The risk was further
increased within the highest quintile.
Conclusions Our results indicate that elevated levels of
endogenous lipogenesis increase the risk of fracture and
suggest a role for saturated fat in the pathogenesis of
osteoporosis.
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Osteoporosis
Introduction
In the last few years, it has become apparent that there is a
reciprocal relationship between the development of bone
and fat. Osteoblasts and marrow adipocytes share a
common mesenchymal progenitor and bone loss is associ-
ated with an expansion of adipose tissue in the marrow [1].
Recent animal studies have shown that the peroxisome
proliferator-activated receptor gamma (PPARγ) pathway,
i.e., the dominant regulator of adipogenesis, inhibits
osteoblast differentiation [2], and that leptin, an anorexi-
genic metabolic hormone that is secreted in proportion to
fat mass, is a regulator of both bone formation and
resorption [3–5].
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stearoyl-CoA desaturase (SCD) may be of particular
interest in this context. SCD is involved in the cellular
biosynthesis of monounsaturated fatty acids (MUFAs) from
saturated fatty acid (SFA) substrates (mainly palmitic and
stearic acid). As a result of substrate channeling the major
MUFAs generated by SCD, i.e., palmitoleic and oleic acid,
represent the main substrates for synthesis of triglycerides,
cholesterol esters and phospholipids. The palmitoleic/
palmitic acid (16:1/16:0) index in serum, also known as
the “desaturation index” has been used to estimated SCD
activity [6, 7]. Consistent with a role as a key point of
metabolic control, SCD activity is tightly regulated, being
decreased by polyunsaturated fatty acids (PUFAs) and
increased by SFAs [8]. Interestingly, SCD-1-null mice
display resistance to obesity and hyperlipidemia [9]. The
levels of palmitoleic acid have been shown to be signifi-
cantly associated with abdominal adiposity in obese female
twins [10] and in obese children [11]. We have recently
shown that the SCD activity index is significantly associ-
ated with obesity in both men and women [12] and that
PPARγ function appears to have a pivotal role in SCD
regulation [7]. This is the first study to investigate the
relation between the SCD activity and risk of fracture.
Methods
Subjects
The Uppsala Longitudinal Study of Adult Men (ULSAM)
has been described previously [13, 14]. Briefly, from 1970
to 1973, we invited all 2,841 men, born 1920–1924, living
in the municipality of Uppsala, Sweden, to participate in a
health survey, the Uppsala Longitudinal Study of Adult
Men. A total of 2,322 men (82% of those invited), 49 to
51 years of age, agreed to participate. At 60 years of age
1,860 men took part in a second evaluation, at 70 years
1,221 men took part in a third evaluation, and at 77 years
839 men participated and finally 530 participated in the
final evaluation at age 82 years. At end of follow-up (Dec
31, 2005), 1295 (56% of the cohort) of these men had died.
SCD activity index
Fasting serum palmitoleic acid and palmitic acid in
ULSAM were analyzed in cholesterol esters by gas-liquid
chromatography after separation of serum lipids by thin-
layer chromatography as previously described [15–17].
Briefly, serum was extracted with a hexane-isopropanol
solution and cholesteryl esters (only lipid esters that were
measured at baseline) were separated from the extract by
thin-layer chromatography before inter-esterification with
acidic methanol was performed. Free cholesterol that had
been liberated in the reaction was removed by aluminium
oxide to avoid contamination of the column. The compo-
sition of methylated fatty acids was determined by gas
chromatography (25 m NB-351 silica capillary column)
with a flame ionization detector and helium as carrier gas.
Every 25th sample was a serum control pool. The CV
between successive gas chromatography runs was 0.2–5%.
A product-to-precursor index (palmitoleic acid 16:1 n-7/
palmitic acid 16:0) was used to estimate SCD activity index
for the 2,009 men for which data were available at baseline.
Identification of cases of fractures
We sought to identify all fractures that occurred among the
study participants after enrollment. We matched the study
cohort to the Hospital Discharge Register to identify cases
treated on an inpatient basis. All orthopaedic records,
radiographic records and outpatient registries at the local
hospitals in areas where the participants in the initial
investigation resided were reviewed to identify out-patient
treated fractures. We censored six cases of fracture caused
by metastatic cancer. Seven cases of fractures due to
suspected high-impact trauma were retained in the analysis
since there are indications of comparable increases of low
and high trauma fracture risk with decreasing bone density
in elderly.
Statistical analysis
We used Cox proportional-hazards models to estimates rate
ratios, with 95% confidence intervals calculated as mea-
sures of associations in the same way as previously
described for serum retinol in the ULSAM cohort [13].
For each man, the number of years of follow-up was
calculated from the date of enrollment (i.e., the date of the
first investigation) until the date of a first fracture or the end
of the follow-up period (December 31, 2005). Dates of
deaths were based on data from the continuously updated
Swedish National Population Register.
SCD activity index levels at baseline at 50 years of age
were evaluated both as a continuous variable and as a
categorical variable, in quintiles. Separate analyses were
performed for fractures specifically designated as osteopo-
rotic (i.e., fractures of the hip, pelvis, spine, distal forearm,
and proximal humerus). The results were similar whether or
not we included the seven cases of fractures due to
suspected high-impact trauma, and these cases were
therefore retained in the analyses. We then estimated the
trend in the risk of fracture by restricted cubic-spline Cox
regression with five “knots” (SCD activity index percentiles
5, 27.5, 50, 72.5, and 95), which enabled us to investigate
extreme SCD values. We used the midpoint of the first
930 Osteoporos Int (2008) 19:929–934quintile, i.e., percentile 10, as reference point in this
analysis. The results of this analysis are presented as
smoothed plots with 95% CI for the overall risk of fracture.
In addition, since fatty acids were analyzed in half of the
men participating in the third evaluation at 70 years (n=611),
we could examine the change of SCD activity index from
age 50 to 70 years and the risk of fracture (in tertiles).
Baseline in this particular analysis was age at the third
investigation and fractures among these 611 men after this
investigation were used as outcome (n=66).
We considered a crude and a multivariable model. The
latter included age, weight, height, serum retinol (all
continuous), smoking (never, former, current), diabetes,
(yes, no), marital status (single, divorced/widowed, married/
cohabitee), any cardiovascular disease (yes, no), self-rated
health (good, not good), and physical activity (low, medium,
high). The estimates remained similar when we also included
sedimentation rate (at age 50), as well as alcohol intake,
dietary energy intake and use of oral calcium and vitamin D
(allatthe age of70years).Consequently,these variables were
omitted from the reported analyses.
The population attributable risk for fracture among those
with a specific SCD-1 level was calculated by
pR R  1 ðÞ
pR R  1 ðÞ þ 1 ½ 
where p is the prevalence of the investigated SCD level
among the fracture cases.
Results
Characteristics of the participants according to the quintile
of SCD-1 activity index at baseline are shown in Table 1.
There was a tendency toward higher weight, higher serum
retinol values, more current smokers, more singles and
divorced men, more circulatory system disease, lower self-
rated health, and lower physical activity in higher quintiles
of SCD-1 activity index. During 51,707 person-years of
follow-up, we identified 422 men (21%) with any fracture
after study entry.
The overall risk of fracture increased by 31% for every
increase of 1 SD in SCD activity index. The increment was
mainly concentrated in the highest quintile for SCD;
multivariable rate ratio for any fracture, as compared with
the lowest quintile, 1.71 (95% CI 1.26–2.33) (Table 2),
with an estimated population attributable risk of 15%. For
fractures at sites that are typical of osteoporotic fractures,
the multivariable rate ratio was 1.91 (95% CI 1.26–2.91).
There was also a trend towards increased risk of hip
fractures when analyzed as a continuous variable (p=0.04),
but the multivariable rate ratio for the highest quintile as
compared with the lowest quintile did not reach statistical
significance, HR 1.4 (95% CI 0.8–2.6).
The risk of fracture was further increased in the highest
quintile for SCD. Subjects with SCD levels in the 95th
percentile had an overall risk of fracture that was about
twice the risk among those with lower levels (crude rate
ratio 2.8 (95% CI 2.0–4.0), multivariable rate ratio 2.2
Table 1 Base-line characteristics of the study participants according to the quintile of SCD activity index levels (SD in parentheses)
Characteristic Quintile Quintile Quintile Quintile Quintile
12345
(0–0.251) (0.251–0.286) (0.286–0.325) (0.325–0.387) (>0.387)
N=401 N=402 N=402 N=403 N=401
Age (years) 49.7 (0.6) 49.7 (0.6) 49.7 (0.6) 49.6 (0.6) 49.7 (0.6)
Height (cm) 176.4 (5.9) 176.3 (6.2) 176.4 (5.9) 176.2 (6.1) 175.5 (5.6)
Weight (kg) 75.0 (9.2) 76.0 (10.3) 78.3 (10.8) 79.8 (12.1) 79.8 (12.2)
Serum retinol (μg/l) 626.8 (140.4) 649.6 (124.5) 649.3 (112.7) 655.1 (121.0) 719.4 (147.1)
Circulatory system disease Yes 3 (0.7%) 7 (1.7%) 7 (1.7%) 9 (2.2%) 11 (2.7%)
Marital status Divorced 13 (3.2%) 19 (4.7%) 14 (3.5%) 14 (3.5%) 32 (8.0%)
Married 356 (88.8%) 345 (86.0%) 361 (90.0%) 353 (87.6%) 316 (79.0%)
Single 26 (6.5%) 32 (8.0%) 22 (5.5%) 32 (7.9%) 44 (11.0%)
Widower 6 (1.5%) 5 (1.2%) 4 (1.0%) 4 (1.0%) 8 (2.0%)
Self-rated health Good 319 (82.0%) 335 (84.6%) 326 (84.2%) 321 (81.7%) 301 (77.0%)
Physical activity Low 37 (9.7%) 57 (14.7%) 49 (13.1%) 58 (15.3%) 80 (20.7%)
Medium 145 (37.9%) 136 (35.1%) 121 (32.3%) 145 (38.3%) 149 (38.5%)
High. 201 (52.5%) 195 (50.3%) 205 (54.7%) 176 (46.4%) 158 (40.8%)
Smoking Current smoker 193 (48.1%) 189 (47.0%) 202 (50.2%) 198 (49.1%) 247 (61.6%)
Former smoker 88 (21.9%) 100 (24.9%) 89 (22.1%) 101 (25.1%) 92 (22.9%)
Never smoked 120 (29.9%) 113 (28.1%) 111 (27.6%) 104 (25.8%) 62 (15.5%)
Diabetes Yes 9 (2.2%) 4 (1.0%) 5 (1.2%) 3 (0.7%) 8 (2.0%)
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had an overall risk that exceeded the risk among men with
levels by a factor of about five (crude rate ratio 6.1 (95% CI
3.3–11.5), multivariable rate ratio 4.52 (95% CI 2.33–8.75)
(Fig. 1).
In half of the men examined at 70 years of age, serum
palmitoleic and palmitic acid were measured (n=611).
Using only fracture data that occurred in this sub-group
(66 fractures), we found a significant correlation between
the change in SCD index and fracture risk (crude rate ratio
for third vs. lowest tertile 3.23 (95% CI 1.50–6.93),
multivariable rate ratio 2.16 (95% CI 1.17–3.98), indicating
that when the SCD activity index increases over time, so
does the risk of fracture. In 454 men waist circumference
was measured at enrollment. There was a moderate, but
highly significant, correlation between SCD activity index
and waist circumference (r=0.22, p<0.001).
Discussion
SCD is a key enzyme in the biosynthesis of MUFAs from
SFAs, i.e., in lipogenesis. In this prospective, population-
based cohort study of men, the overall risk of fracture was
substantially increased among the men with high levels of
estimated SCD activity. The risk was concentrated in the
highest quintile, with a continuous increase within this
category, and it was independent of BMI. Thus, despite a
positive effect of increased fat mass on weight-bearing, our
results indicate that increased endogenous lipogenesis has
negative effects on bone. Although we could only analyze a
subgroup, the finding that an increase in SCD activity index
from 50 to 70 years is associated with an even higher risk,
gives further support to this.
We included not only height and weight in our
multivariable model, but also a number of lifestyle factors.
Adjustment for these factors had only modest effects on the
estimates, indicating that the association between SCD
activity index and fracture risk cannot be explained by these
potential confounders. Instead our results suggest that the
dietary fat quality and endogenous fatty acid metabolism
may be important. It should be emphasized that increased
SCD activity index does not directly reflect increased
proportions of palmitoleic acid in the diet, since the content
of this fatty acid is normally small in the diet. Rather, it
reflects increased endogenous desaturation of palmitic acid
by SCD leading to increased palmitoleic acid, as a
consequence of a high intake of palmitic acid in the diet
[11]. Interestingly, in glycogen storage disease type 1, the
synthesis of palmitic acid is increased 40-fold [18] and
osteopenia is a known complication in this disease [19–22].
Furthermore, in animal studies, inclusion of palmitic acid as
the major source of fat causes a reduction in bone ash and
bone calcium levels [23, 24].
Alternatively, although unlikely in a Western diet with a
high dietary intake of fat [25], an increased SCD activity
index could be a consequence of a high intake of
carbohydrates. At low fat intakes, the amount of palmitoleic
acid in serum has been reported to reflect the hepatic pool of
carbon flux from carbohydrates to fatty acids [26], e.g., in
rats rendered obese by sucrose administration, SCD activity
index increases dramatically in liver and plasma [27].
SFAs, high carbohydrate diets, and insulin all appear to
be able to induce SCD expression, whereas dietary PUFAs
and leptin seem to inhibit SCD mRNA transcription [11].
Therefore, the relationship between SCD and risk of
fracture may reflect compensatory up-regulation of SCD
to continuous intake of e.g., a diet high in SFAs (such as
dairy products, solid margarines, and meat products) and
low in PUFAs, rather than a metabolically harmful effect of
increased activity in itself [17]. Consistent with this, a
Fig. 1 Smoothed plot of rate ratios for any fracture according to the
adjusted SCD activity index level at baseline
Table 2 Rate ratios (RRs) with 95% confidence intervals (95% CI) of
any fracture by SCD activity index at baseline at 50 years
Category n fractures Univariate analysis Multivariable*
analysis
RR 95% CI RR 95% CI
Quintile 1 83 1.0 Ref 1.0 Ref
Quintile 2 84 1.03 0.76–1.40 1.04 0.77–1.41
Quintile 3 77 1.05 0.77–1.43 1.09 0.80–1.50
Quintile 4 73 1.08 0.79–1.48 1.07 0.77–1.47
Quintile 5 105 1.91 1.43–2.55 1.71 1.26–2.33
Per 1 SD 1.38 1.26–1.50 1.31 1.19–1.44
P value <0.001 <0.001
* Adjusted for age, height, weight, serum retinol (all continuous),
smoking status (never, former, current smoker), diabetes (yes/no),
marital status (single, divorced/widowed, married/cohabiting), circula-
tory system disease (yes/no), self-rated health (good, not good), and
physical activity (low, medium, high).
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that SFAs are inversely associated with bone density at
several hip sites, particularly in men <50 years of age.
SCD activity can also be estimated as the oleic/stearic
acid (18:1/18:0) ratio [6]. However, the predictive value of
this ratio in serum in the ULSAM cohort has previously
been shown to be considerably less than for palmitoleic/
palmitic acid due to a much higher dietary proportion of
oleic acid [17], and was therefore not analyzed in this study.
Mounting evidence indicates an important role of
PPARγ in skeletal metabolism. PPARγ haploinsufficient
mice have increased bone mass and decreased adipo-
genesis, whereas activation of PPARγ with the agonist
rosiglitazone causes bone loss and increased bone marrow
adiposity in mice [29, 30]. Thiazolidinedione use has
recently been shown to cause bone loss also in humans
[31]. In a randomized clinical trial rosiglitazone increased
SCD activity index, and in one patient with partial
lipodystrophy and type 2 diabetes due to dominant-negative
mutation in the PPARγ gene, it restored SCD activity
index, indicating a pivotal role of PPARγ function in SCD
regulation, at least in adipose tissue [7]. The activation of
PPARγ by natural ligands, such as oxidized fatty acids,
plays an important role in the development of atheroscle-
rosis [32]. Oxidized lipids also inhibit osteoblast develop-
ment in vitro and bone formation in vivo, and serve as
substrates for PPARγ, which redirects differentiation of
mesenchymal cells from osteoblasts to adipocytes. PPAR
also enhances many adipocyte genes and diminishes Cbfa1/
Runx2, needed for osteoblast development. All these effects
could reduce bone formation and promote atherogenesis
[33]. Atherosclerosis could be one of the common factors
which would explain the reported relationship between
cardiovascular disease and osteoporosis [34]. Our findings
are consistent with previous findings from the ULSAM
cohort regarding serum fatty acid profile and the risk of
developing cardiovascular disease [16, 35]. Moreover,
inflammation plays an important role in atherogenesis. Part
of the inflammatory response is activation of T cells with
release of cytokines, especially of RANKL, which is a key
molecule in bone resorption [33].
We have previously found an association between serum
retinol and fracture risk in ULSAM (12). Retinol is a fat-
soluble vitamin found in dietary fat from animal sources, i.e.,
in food that may also contain high levels of SFAs. However,
inclusion of retinol in the multivariable model had only
minor effects on the rate ratio.
Our population-based study had the advantage of
involving men with similar age followed from a time
before they reached the high incidence ages for fractures,
and we used hospital-record verification of fractures. In
addition, we used serum levels of individual fatty acids,
rather than dietary assessments of fat intake.
There are some limitations of this study. The study
population consisted only of men and therefore our results
need to be verified in women. Since direct measures of
SCD activity is very difficult to obtain in larger studies, we
used the ratio between two fatty acids. Whether the ratio
mainly reflects SCD activity in adipose tissue, liver, or both
still remains to be elucidated. Unfortunately, bone mineral
density data were not available. Another limitation of the
study is the lack of dietary records at baseline and the
resulting lack of knowledge about the intake of e.g., SFAs
and PUFAs in the studied population.
In conclusion, the results of our study suggest that a high
SCD activity, indicating elevated endogenous lipogenesis,
substantially increases the risk of fractures. Previous exper-
imental work showing a reciprocal relationship between
bone and fat supports this conclusion.
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